{"entity":{"type":"insider","cik":"0001840407","url":"/insider/0001840407","json_url":"/insider/0001840407.json","name":"Liu Ye","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2023-05-31","last":"2024-01-16","span_basis":"filed_date"},"name_variants":[{"name":"Liu Ye","source":"filing","n_filings":3,"first_seen":"2023-05-31","last_seen":"2024-01-16"}],"transactions":[{"id":3128683,"accession":"0001562180-24-000466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-000466","line_url":"/filing/0001562180-24-000466#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001840407","owner_name":"Liu Ye","owner_display_name":"Liu Ye","owner_url":"/insider/0001840407","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1910500.0,"shares_display":"1,910,500","price_per_share":19.45,"price_display":"19.45","price_state":"stated","total_value":37159225.0,"total_display":"37,159,225.00","total_whole":"37,159,225","shares_owned_after":100221.0,"shares_owned_after_display":"100,221","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-16","scope":"insider"},{"id":8450442,"accession":"0001562180-23-008222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-008222","line_url":"/filing/0001562180-23-008222#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001840407","owner_name":"Liu Ye","owner_display_name":"Liu Ye","owner_url":"/insider/0001840407","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":266242.0,"shares_display":"266,242","price_per_share":18.41,"price_display":"18.41","price_state":"stated","total_value":4901515.22,"total_display":"4,901,515.22","total_whole":"4,901,515","shares_owned_after":2010721.0,"shares_owned_after_display":"2,010,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-07","scope":"insider"},{"id":8450438,"accession":"0001562180-23-008222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-008222","line_url":"/filing/0001562180-23-008222#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001840407","owner_name":"Liu Ye","owner_display_name":"Liu Ye","owner_url":"/insider/0001840407","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733758.0,"shares_display":"733,758","price_per_share":19.91,"price_display":"19.91","price_state":"stated","total_value":14609121.78,"total_display":"14,609,121.78","total_whole":"14,609,122","shares_owned_after":2276963.0,"shares_owned_after_display":"2,276,963","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-07","scope":"insider"},{"id":8302412,"accession":"0001562180-23-004632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-004632","line_url":"/filing/0001562180-23-004632#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":"0001840407","owner_name":"Liu Ye","owner_display_name":"Liu Ye","owner_url":"/insider/0001840407","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":6.0,"total_display":"6.00","total_whole":"6","shares_owned_after":3010721.0,"shares_owned_after_display":"3,010,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-05-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint Pharmaceuticals, Inc.","url":"/issuer/0001314102","role":"Director","n_filings":3,"first_seen":"2023-05-31","last_seen":"2024-01-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001840407","retrieved_at":"2026-08-22T05:41:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}